Marinus Pharmaceuticals (NASDAQ:MRNS) Cut to Sell at StockNews.com : vimarsana.com

StockNews.com lowered shares of Marinus Pharmaceuticals (NASDAQ:MRNS – Free Report) from a hold rating to a sell rating in a research note released on Wednesday morning. MRNS has been the subject of several other reports. Truist Financial reduced their target price on shares of Marinus Pharmaceuticals from $32.00 to $25.00 and set a buy rating […]

Related Keywords

Canada , Blackrock , Nova Scotia , Lion Point , Northwest Territories , , Institutional Trading Of Marinus Pharmaceuticals , Marinus Pharmaceuticals Stock , Marinus Pharmaceuticals , Analyst Recommendations For Marinus Pharmaceuticals , Marinus Pharmaceuticals Inc , Blackrock Inc , Eventide Asset Management , Royal Bank , Franklin Resources Inc , News Ratings For Marinus Pharmaceuticals Daily , Free Report , Moderate Buy , Get Free Report , Asset Management , Point Capital , Marinus Pharmaceuticals Daily ,